Skip to content
DataLookout
Menu

LIFTNCT07925619

Efficacy and Safety Study of L608 in Patients With Systemic Sclerosis-associated Digital Ulcers

StatusNot Yet Recruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Time to healing of the cardinal DU
Timeframe: up to 12 weeks

Arms and interventions

L608Experimental
PlaceboPlacebo comparator

Drugs: L608, Placebo